Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

19.71

+0.32 (1.65%)

At close: May 29, 2026, 4:00 PM EDT

19.80

+0.09 (0.46%)

After-hours: May 29, 2026, 7:52 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,665	1,028	427	283	375	950
Market Cap Growth	631.63%	140.76%	50.68%	-24.53%	-60.50%	-
Enterprise Value	1,038	685.42	93.71	93.76	156.4	604.19
Last Close Price	19.71	15.68	6.94	5.65	7.61	20.42
PS Ratio	38.77	8.31	5.64	-	-	-
PB Ratio	3.18	4.41	1.91	1.58	1.38	2.73
P/TBV Ratio	3.29	5.59	2.30	1.62	1.32	1.47
P/FCF Ratio	-	-	11.23	-	-	-
P/OCF Ratio	-	-	10.16	-	-	-
EV/Sales Ratio	24.16	5.54	1.24	-	-	-
EV/FCF Ratio	-	-	2.47	-	-	-
Debt / Equity Ratio	0.07	0.15	0.17	0.24	0.16	0
Debt / FCF Ratio	-	-	1.12	-	-	-
Net Debt / Equity Ratio	-1.20	-1.45	-1.48	-1.04	-0.79	-1.00
Net Debt / EBITDA Ratio	4.48	7.37	4.51	1.36	1.99	4.89
Net Debt / FCF Ratio	31.91	12.29	-8.67	2.97	2.05	5.01
Asset Turnover	0.07	0.28	0.20	0	0	0
Quick Ratio	9.44	6.05	2.37	5.00	10.58	20.80
Current Ratio	9.54	6.12	2.40	5.07	10.79	20.96
Return on Equity (ROE)	-34.44%	-16.94%	-36.15%	-60.07%	-35.06%	-40.35%
Return on Assets (ROA)	-24.67%	-11.88%	-22.65%	-44.47%	-31.71%	-35.06%
Return on Invested Capital (ROIC)	-374.70%	-146.63%	-220.77%	-279.75%	-370.04%	-8554.23%
Return on Capital Employed (ROCE)	-28.25%	-16.27%	-30.10%	-49.94%	-33.72%	-39.42%
FCF Yield	-	-	8.90%	-	-	-
Buyback Yield / Dilution	-9.92%	-12.40%	-43.80%	-8.83%	-88.91%	-1548.09%
Total Shareholder Return	-9.92%	-12.40%	-43.80%	-8.83%	-88.91%	-1548.09%

SEC Filings: 10-K · 10-Q